This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Timothy Lowinger, Ph.D.
Chief Science & Technology Officer at Mersana Therapeutics, Inc.


Tim Lowinger is the Chief Science and Technology Officer at Mersana Therapeutics, a clinical stage ADC company. Tim is a co-inventor of Mersana’s novel ADC platforms and pipeline, including Dolaflexin, Dolasynthen and Immunosynthen. Previously, Tim rose through the ranks of medicinal chemistry at Bayer, where he was a co-inventor of the approved drugs Nexavar and Stivarga, and was most recently head of Chemistry in the US.

Agenda Sessions

  • XMT-2056: Targeted STING Agonism Via An Immunosynthen Antibody Drug Conjugate